ACLX-9.28%8.3%
BBOT-10.40%8.3%
BMY+41.97%8.3%
CMPX-35.05%8.3%
GMAB+36.03%8.3%
JAZZ+146.93%8.3%
KURA+52.57%8.3%
LEGN-49.42%8.3%
NRIX+140.15%8.3%
NUVL+60.51%8.3%
RVMD+438.04%8.3%
ZYME+89.36%8.3%
As of Aug 6, 2026, 4:25 AM ET
Biotech '26: Scalable Oncology Drugs Constituents
Arcellx, Inc.ACLX | 8.3% | 0.00% | 0.00% | 0.00% | 0.00% | -1.67% | 0.00% | -4.64% | -9.28% | $3.75B |
BridgeBio Oncology Therapeutics Inc.BBOT | 8.3% | 1.01% | 1.59% | 6.54% | 10.75% | -28.43% | -10.67% | -10.40% | -10.40% | $717.8M |
Bristol-Myers Squibb CompanyBMY | 8.3% | -3.43% | 2.48% | 12.22% | -2.57% | 17.96% | 2.02% | 7.92% | 41.97% | $129.94B |
Compass Therapeutics, Inc.CMPX | 8.3% | -4.55% | -8.70% | -17.47% | -1.05% | -64.80% | -66.55% | 11.83% | -35.05% | $261.4M |
Genmab A/SGMAB | 8.3% | 0.83% | 1.35% | 4.46% | 1.35% | -5.00% | -0.61% | 55.47% | 36.03% | $17.96B |
Jazz Pharmaceuticals plcJAZZ | 8.3% | -0.02% | 3.03% | 7.13% | 3.44% | 53.86% | 37.65% | 106.87% | 146.93% | $16.43B |
Kura Oncology, Inc.KURA | 8.3% | -2.85% | -11.45% | -16.67% | 2.11% | -11.45% | 5.38% | 41.10% | 52.57% | $816.7M |
Legend Biotech CorporationLEGN | 8.3% | -0.42% | -14.27% | -32.06% | 2.70% | -12.37% | 0.26% | -42.69% | -49.42% | $3.52B |
Nurix Therapeutics, Inc.NRIX | 8.3% | 1.74% | 7.44% | 4.49% | 8.23% | 32.42% | 57.29% | 120.74% | 140.15% | $2.61B |
Nuvalent, Inc.NUVL | 8.3% | 0.00% | 0.00% | 0.19% | 0.00% | 23.23% | 21.59% | 75.93% | 60.51% | $9.13B |
Revolution Medicines, Inc.RVMD | 8.3% | 1.98% | 4.26% | 3.85% | 5.21% | 147.71% | 93.39% | 470.23% | 438.04% | $41.95B |
Zymeworks Inc.ZYME | 8.3% | 3.12% | 2.80% | -7.22% | 7.11% | -10.75% | 0.90% | 97.15% | 89.36% | $1.73B |
| Theme return | — | -0.22% | -0.96% | -3.98% | 3.09% | 13.10% | 14.27% | 76.89% | 62.05% | — |
| Average | 8.3% | -0.22% | -0.96% | -2.88% | 3.11% | 11.73% | 11.72% | 77.46% | 75.12% | $19.07B |
| Median | 8.3% | 0.00% | 1.47% | 2.02% | 2.41% | -3.33% | 1.46% | 48.29% | 47.27% | $3.64B |
| Std Dev | 0.0% | 2.21% | 6.46% | 12.45% | 3.85% | 50.35% | 37.43% | 128.21% | 124.74% | $35.35B |
| Min | 8.3% | -4.55% | -14.27% | -32.06% | -2.57% | -64.80% | -66.55% | -42.69% | -49.42% | $261.4M |
| Max | 8.3% | 3.12% | 7.44% | 12.22% | 10.75% | 147.71% | 93.39% | 470.23% | 438.04% | $129.94B |
| % Positive Tickers | 41.67% | 58.33% | 58.33% | 66.67% | 41.67% | 66.67% | 75.00% | 66.67% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
Biotech '26: Scalable Oncology Drugs tracks 12 publicly listed stocks in this theme: ACLX, BBOT, BMY, CMPX, GMAB, JAZZ, KURA, LEGN, NRIX, NUVL, RVMD, ZYME. See the constituent table for details.